Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE stock opened at $0.09 on Thursday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $2.91. The stock has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.02. The firm has a market cap of $97,723.50, a P/E ratio of -0.01 and a beta of 3.71.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.